相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
Kenneth Smith et al.
VACCINE (2012)
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin
Siham Chahboun et al.
BMC BIOTECHNOLOGY (2011)
Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo
Stephen F. Little et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Diagnostic and Possible Therapeutic Application of a Monoclonal Antibody (14G8) Directed Against botulinum Type C Neurotoxin
Vicki A. Montgomery et al.
HYBRIDOMA (2011)
Epitope Characterization of Sero-Specific Monoclonal Antibody to Clostridium botulinum Neurotoxin Type A
Cindi R. Corbett et al.
HYBRIDOMA (2011)
Passive vaccination with a human monoclonal antibody: Generation of antibodies and studies for efficacy in Bacillus anthracis infections
Ulrich vor dem Esche et al.
IMMUNOBIOLOGY (2011)
Mouse Monoclonal Antibodies to Anthrax Edema Factor Protect against Infection
Clinton E. Leysath et al.
INFECTION AND IMMUNITY (2011)
Generation, Characterization, and Epitope Mapping of Neutralizing and Protective Monoclonal Antibodies against Staphylococcal Enterotoxin B-induced Lethal Shock
Avanish K. Varshney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of a Novel Functional Domain of Ricin Responsible for Its Potent Toxicity
Jianxing Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis
Parul Kulshreshtha et al.
MOLECULAR IMMUNOLOGY (2011)
Antibodies for biodefense
Jeffrey W. Froude et al.
MABS (2011)
Antibody-based therapeutics to watch in 2011
Janice M. Reichert
MABS (2011)
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
Jody D. Berry et al.
NEW BIOTECHNOLOGY (2011)
Neutralising Antibodies against Ricin Toxin
Julie Prigent et al.
PLOS ONE (2011)
Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule
Zhaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis
Siu-Kei Chow et al.
VACCINE (2011)
Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)
Anastasiya Yermakova et al.
VACCINE (2011)
A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin
Lori M. Neal et al.
INFECTION AND IMMUNITY (2010)
Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric Antibodies
Mulualem E. Tilahun et al.
INFECTION AND IMMUNITY (2010)
Neutralizing Monoclonal Antibody to Edema Toxin and Its Effect on Murine Anthrax
Lisa Winterroth et al.
INFECTION AND IMMUNITY (2010)
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
Nareen Abboud et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Development trends for human monoclonal antibody therapeutics
Aaron L. Nelson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Respiratory syncytial virus market
Shane Storey
NATURE REVIEWS DRUG DISCOVERY (2010)
Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity
Christelle Mazuet et al.
PLOS ONE (2010)
Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B
Eileen A. Larkin et al.
PLOS ONE (2010)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai et al.
SCIENCE (2010)
Folding domains within the ricin toxin A subunit as targets of protective antibodies
Joanne M. O'Hara et al.
VACCINE (2010)
Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B
Heyue Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
Thibaut Pelat et al.
BMC BIOTECHNOLOGY (2009)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody
Zhaochun Chen et al.
INFECTION AND IMMUNITY (2009)
Neutralizing Monoclonal Antibodies Directed against Defined Linear Epitopes on Domain 4 of Anthrax Protective Antigen
Cassandra D. Kelly-Cirino et al.
INFECTION AND IMMUNITY (2009)
Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies
Nareen Abboud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cellular and systemic effects of anthrax lethal toxin and edema toxin
Mahtab Moayeri et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
Glycosylation as a strategy to improve antibody-based therapeutics
Roy Jefferis
NATURE REVIEWS DRUG DISCOVERY (2009)
Isolation and Chimerization of a Highly Neutralizing Antibody Conferring Passive Protection against Lethal Bacillus anthracis Infection
Ronit Rosenfeld et al.
PLOS ONE (2009)
Monoclonal antibody-based therapies for microbial diseases
Carolyn Saylor et al.
VACCINE (2009)
Molecular engineering and design of therapeutic antibodies
Leonard G. Presta
CURRENT OPINION IN IMMUNOLOGY (2008)
A human monoclonal antibody that binds serotype a botulinum neurotoxin
Sharad P. Adekar et al.
HYBRIDOMA (2008)
A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo
Sharad P. Adekar et al.
HYBRIDOMA (2008)
Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant
Yong Sung Park et al.
INFECTION AND IMMUNITY (2008)
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
Sharad P. Adekar et al.
PLOS ONE (2008)
Characterization of monoclonal immunoglobulin A and G against Shiga toxin binding subunits produced by intranasal immunization
T. Tanikawa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity
Herman F. Staats et al.
INFECTION AND IMMUNITY (2007)
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax
Mark T. Albrecht et al.
INFECTION AND IMMUNITY (2007)
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation
Thibaut Pelat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule
Thomas R. Kozel et al.
INFECTION AND IMMUNITY (2007)
Antibody therapeutics: isotype and glycoform selection
Roy Jefferis
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity
Laura Vitale et al.
INFECTION AND IMMUNITY (2006)
Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen
Michael J. Gubbins et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1
Johanna Rivera et al.
INFECTION AND IMMUNITY (2006)
Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit
Carolyn R. McGuinness et al.
INFECTION AND IMMUNITY (2006)
Ooutlook - Anti-infective monoclonal antibodies: perils and promise of development
JM Reichert et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen
ZC Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication
NJ Mantis et al.
INFECTION AND IMMUNITY (2006)
An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin
NK Lim et al.
INFECTION AND IMMUNITY (2005)
Monoclonal antibodies to ricin:: In vitro inhibition of toxicity and utility as diagnostic reagents
MT Dertzbaugh et al.
HYBRIDOMA (2005)
Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694
E Laffly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia
TR Kozel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Isolation and characterization of a neutralizing antibody specitic to internalization domain of Clostridium botulinum neurotoxin type B
GH Yang et al.
TOXICON (2004)
Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies
F Brossier et al.
INFECTION AND IMMUNITY (2004)
Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages
N Mohamed et al.
INFECTION AND IMMUNITY (2004)
Immunological characteristics associated with the protective efficacy of antibodies to ricin
M Maddaloni et al.
JOURNAL OF IMMUNOLOGY (2004)
Production and characterization of protective human antibodies against shiga toxin 1
J Mukherjee et al.
INFECTION AND IMMUNITY (2002)
Characterization of a neutralizing monoclonal antibody against botulinum ADP-ribosyltransferase, C3 exoenzyme
Y Kamata et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2002)
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
A Nowakowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
JA Maynard et al.
NATURE BIOTECHNOLOGY (2002)
Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H17 infection
J Mukherjee et al.
INFECTION AND IMMUNITY (2002)
Monoclonal antibody to Shiga toxin 1, which blocks receptor binding and neutralizes cytotoxicity
H Nakao et al.
MICROBIOLOGY AND IMMUNOLOGY (2002)
Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A
HC Wu et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Infectivity-enhancing antibodies to ebola virus glycoprotein
A Takada et al.
JOURNAL OF VIROLOGY (2001)
High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A
DD Pless et al.
INFECTION AND IMMUNITY (2001)
Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody
LTY Pang et al.
INFECTION AND IMMUNITY (2000)
分享论文
